An in-depth look to STAYBLE THERAPEUTICS AB operating, investing, and financing activities

STABL free cash flow for Q2 24 is -1.59 M SEK. For 2023, STABL free cash flow was -23.54 M SEK and operating cash flow was -23.54 M SEK.